MEDVis digital portal also serves as a resource hub offering reminders, guidance on nutrition, and structured support for long-term adherence
OLeary et al., using diagnostic codes, found that GLP-1 RA (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide) use was associated with a reduction in the odds of visual loss: at 6 months, OR 0.423 (95% CI 0.3240.546), and at 1 year, OR 0.606 (0.4890.747), compared to matched controls [37]
It was developed to provide a chemically well-characterised molecule suitable for controlled investigation of short peptide signalling in cellular and molecular research systems
The results are not directly comparable to systemic Thymosin Beta-4 or TB-500 administration Key distinction: TB-500 is a synthetic fragment designed to mimic aspects of Thymosin Beta-4
It is available at all leading pharmacies across Pakistan